Skip to main content

What the FDA labels say about taking them together

Dabigatran and lenacapavir

Lenacapavir's FDA label of August 27, 2026 names dabigatran in its drug interactions section; the dabigatran labels PlainMeds reads (2) do not name lenacapavir.

Check it at the source: the dabigatran FDA label on DailyMed (effective June 25, 2025, Boehringer Ingelheim Pharmaceuticals Inc.); the lenacapavir FDA label on DailyMed (effective August 27, 2026, Gilead Sciences, Inc.).

What does the dabigatran label say about lenacapavir?

Dabigatran's label (effective June 25, 2025) and its 1 other brand-application label do not name lenacapavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Pradaxa), Boehringer Ingelheim Pharmaceuticals Inc., effective June 25, 2025 (SPL set ba74e3cd-b06f-4145-b284-5fd6b84ff3c9), via openFDA; the full label on DailyMed

What does the lenacapavir label say about dabigatran?

Lenacapavir label, drug interactions

Concomitant Drug Class/Drug Name: Anticoagulants: Direct Oral Anticoagulants (DOACs) rivaroxaban dabigatran edoxaban; Effect on Concentration ↑ = Increase, ↓ = Decrease.: ↑ DOAC; Clinical Comment: Refer to the DOAC prescribing information for concomitant administration with moderate CYP3A inhibitors and/or P-gp inhibitors.

Source: FDA drug label (Sunlenca), Gilead Sciences, Inc., effective August 27, 2026 (SPL set e5652804-29c4-40d7-aeb2-0142ed2a7b5b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Dabigatran generic labelers
0Lenacapavir generic labelers
DabigatranLenacapavir
Labeled forAtrial fibrillation, Blood clots (DVT and PE), Stroke preventionHIV
Boxed warningYesNo
Pharmacy cost (NADAC)$0.795 per capsule 150 mg capsulen/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?